Aethlon Medical granted Nasdaq extension to Oct 23, 2023 to regain $1 bid price compliance

AETHLON MEDICAL INC

Nasdaq approved extension request on April 25, 2023 after original deficiency notice on Oct 25, 2022.
Company now has until October 23, 2023 to show bid price closed at $1.00 or more for 10 consecutive days.
Risk remains: no assurance compliance will be achieved or other Nasdaq requirements met.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.